Interview with Dr. Thomas Costa of Coventya

ndetails

In the new episode of the alpha Talks Podcast, Enno Krey speaks to Dr. Thomas Costa, former CEO of Coventya (acquired by MacDermid Enthone in 2021), a leading international specialty chemicals company. Thomas has successfully led Coventya through 20 years of PE ownership before it was acquired by Element Solutions Inc (NYSE:ESI) this year.

Thomas speaks about his journey and the lessons learnt as a successful Private Equity CEO.

Listen to the podcast:

You can subscribe to the podcast on Spotify:

Spotify

alpha Talks is the podcast dedicated to Private Equity value growth. Enno speaks to experienced buyout CEOs, operating partners, deal makers and advisors about their experience and lessons-learned in the industry.

Related Insights

Alpha Talks: What to do in your first 100 days as a $1bn company CEO | Jon Newhard, Yunex Traffic CEO
07 Nov, 2025 By Alex Read , Andros Payne

Alpha Talks: What to do in your first 100 days as a $1bn company CEO | Jon Newhard, Yunex Traffic CEO

Alpha Talks: What to do in your first 100 days as a $1bn company CEO | Jon Newhard, Yunex Traffic CEO What should a new…

Read more arrowicon
CEO Succession: How to avoid the pitfalls and unlock the value
03 Nov, 2025 By JenJee Chan

CEO Succession: How to avoid the pitfalls and unlock the value

CEO Succession: How to avoid the pitfalls and unlock the value Poorly managed CEO and C-suite transitions in the S&P 1500 companies are estimated to…

Read more arrowicon
Combatting 50%+ Increase in Leadership Turnover:  Driving Performance in the Age of Continuation Funds
21 Oct, 2025 By Andreas Knobloch

Combatting 50%+ Increase in Leadership Turnover: Driving Performance in the Age of Continuation Funds

Continuation Funds Surge Continuation fund transactions surged to $63 billion in 2024, driven by a liquidity drought that left 29,000 unsold portfolio companies globally, valued…

Read more arrowicon

Subscribe to our Monthly Newsletter and other News Updates

Receive our news and valuable perspectives on organizational effectiveness each month.